实验研究
ENGLISH ABSTRACT
改性壳聚糖滴眼液对兔白念珠菌性角膜炎的治疗作用及安全性评价
杨瑞波
高奕晨
朱萌
牛忠伟
张琛
刘慧
黄悦
高云华
赵少贞
作者及单位信息
·
DOI: 10.3760/cma.j.issn.2095-0160.2020.03.003
Efficacy and safety of modified chitosan eye drops in the treatment of Candida albicanskeratitis in rabbits
Yang Ruibo
Gao Yichen
Zhu Meng
Niu Zhongwei
Zhang Chen
Liu Hui
Huang Yue
Gao Yunhua
Zhao Shaozhen
Authors Info & Affiliations
Yang Ruibo
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Gao Yichen
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Zhu Meng
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Niu Zhongwei
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Zhang Chen
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Liu Hui
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Huang Yue
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
Gao Yunhua
Technical Institute of Physics and Chemistry Chinese Academy of Sciences, Beijing 100190, China
Zhao Shaozhen
Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
·
DOI: 10.3760/cma.j.issn.2095-0160.2020.03.003
761
66
0
0
1
0
PDF下载
APP内阅读
摘要

目的评价改性壳聚糖滴眼液在白念珠菌性角膜炎动物模型中的治疗作用及安全性。

方法选取10只健康成年雌性新西兰白兔,以右眼为实验眼,采用角膜接触镜法建立浅层白念珠菌性角膜炎模型。经裂隙灯显微镜及角膜刮片显微镜检查结果初步判定造模成功的新西兰白兔,采用随机数字表法分为模型组和改性壳聚糖点眼组,根据真菌培养结果最终判定造模成功的模型兔,另选5只兔为正常对照组,不做处理。正常对照组和改性壳聚糖点眼组局部给予改性壳聚糖滴眼液点眼,每日6次,1周后改为每日4次,继续用药1周后停药;模型组不给予治疗。用药期间每天裂隙灯显微镜下观察各组角膜病灶及眼表变化,于造模后第1、7、14、21、28天行裂隙灯显微镜照相并进行眼部症状评分,并记录角膜愈合时间。停药后继续观察各组实验眼角膜情况2周。

结果8只模型兔实验眼角膜刮片显微镜检查结果为真菌菌丝和孢子阳性,培养分离的菌株与接种菌株一致,造模成功率为80%(8/10)。造模后第7、14、21天,模型组感染程度评分分别为(14.50±0.58)、(6.25±0.50)和(2.50±0.58)分,明显高于相应时间点改性壳聚糖点眼组的(7.25±1.26)、(2.75±0.50)和(1.25±0.50)分,差异均有统计学意义(均P<0.05)。模型组于造模后7 d内,角膜水肿明显加重,中央白色溃疡范围增大,造模后7~28 d角膜溃疡逐渐愈合,平均愈合时间为(24.5±2.6)d,最终遗留角膜瘢痕及新生血管。改性壳聚糖点眼组造模后7 d内角膜浸润明显减轻,造模后14 d角膜刮片镜检及真菌培养结果均为阴性,平均愈合时间为(13.5±1.3)d,明显短于模型组,差异有统计学意义(t=7.47,P<0.01)。造模后28 d改性壳聚糖点眼组实验眼未见角膜炎复发,治愈率为100%。正常对照组局部用药期间未见眼睑结膜充血水肿及角膜损伤表现。

结论改性壳聚糖滴眼液治疗兔眼浅层白念珠菌性角膜炎模型安全、有效,眼表刺激性小。

角膜炎;白念珠菌;改性壳聚糖;治疗作用
ABSTRACT

ObjectiveTo evaluate the clinical efficacy and safety of modified chitosan eye drops on rabbit Candida albicans keratitis model.

MethodsTen healthy female New Zealand rabbits were used to establish the superficial Candida albicans keratitis model by the corneal surface lens method in the right eye.Slit lamp microscopy and corneal scraping and microscopic examination were performed to preliminarily determine whether the keratitis model has been successfully established, the rabbits were then randomly divided into a model group and a modified chitosan group by the random number table method.The successfully established rabbit models which were determined by fungal culture results were retained.Five normal rabbits receiving no intervention served as a normal control group.The experimental eyes in the normal control and modified chitosan groups were treated with modified chitosan eye drops, Six times a day for one week, and subsequently four times a day for one week.No treatment was administered to the model group.The changes of corneal lesions and ocular surfaces were examined by slit lamp microscopy every day.At 1, 7, 14, 21 and 28 days after modeling, the eye condition and corneal clinical scores was assessed by slit lamp microscopy.The corneal conditions in each group was observed for two weeks after drug withdrawal.

ResultsThe corneal scraping and microscopic examination results of eight rabbits models showed that the fungal hyphae and spores were positive.The fungal culture results showed that the separated pathogen was Candida albicans.The success rate of modeling was 80%(8/10). The clinical scores in the model group at 7, 14 and 21 days after modeling were 14.50±0.58, 6.25±0.50 and 2.50±0.58, respectively, and were significantly higher than 7.25±1.26, 2.75±0.50 and 1.25±0.50 in the modified chitosan group (all at P<0.05). In the model group, corneal edema was significantly aggravated, and the central white ulcer area was enlarged within seven days after modeling.Between 7 and 28 days after modeling, the corneal ulcer was gradually healed, while the central corneal scar and neovascularization were remained.The average healing time was (24.5±2.6)days.In the modified chitosan group, the corneal infiltration was significantly alleviated within seven days after modeling, and the fungal hyphae and spores of corneal scraping were negative on the 14th day after modeling.The average healing time in the modified chitosan group was (13.5±1.3)days, which was significantly shorter than that in the the model group (P<0.01). No recurrence of keratitis was observed in the modified chitosan group after two weeks of drug withdrawal.The cure rate was 100%.In the normal control group, the conjunctival hyperemia, corneal edema, and lesions were not observed during topical administration.

ConclusionThe treatment with modified chitosan eye drop is effective in a rabbit superficial Candida albicans keratitis model, and have no obvious toxic effects on ocular tissues.

Keratitis;Candida albicans;Modified chitosan;Therapeutic effect
Zhao Shaozhen, Email: mocdef.aabnis7991zsoahz
引用本文

杨瑞波,高奕晨,朱萌,等. 改性壳聚糖滴眼液对兔白念珠菌性角膜炎的治疗作用及安全性评价[J]. 中华实验眼科杂志,2020,38(03):169-174.

DOI:10.3760/cma.j.issn.2095-0160.2020.03.003

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
真菌性角膜炎(fungal keratitis,FK)是发病率和致盲率均较高的感染性角膜炎,并已成为中国部分地区主要致盲角膜疾病 [ 1 ]。由于临床抗真菌药物存在种类有限,对眼表刺激性大,角膜穿透性差,全身应用毒性和不良反应显著等问题 [ 2 , 3 ],FK的临床药物治疗较细菌性角膜炎更加棘手。FK的手术治疗近年来虽取得一定成效,但仍面临供体角膜材料缺乏、手术费用较高及FK复发等问题 [ 4 , 5 ],限制其临床广泛开展。因此,眼表刺激性小、组织穿透性好、高效低毒的新型抗真菌药物亟需开发与应用。壳聚糖抗菌活性强,可有效抑制金黄色葡萄球菌、大肠杆菌、白念珠菌,且具有细胞毒性低、生物相容性良好等优点 [ 6 , 7 ]。然而,由于壳聚糖难溶于水和有机溶剂,使其生物应用受到限制。本研究组通过调控正电荷与亲疏水性平衡制备了具有良好水溶性的改性壳聚糖。前期实验证实改性后的壳聚糖具有良好的生物安全性,对皮肤、眼及阴道黏膜均无刺激性、无致敏性、无细胞毒性及生殖毒性且具有控制细菌感染与促进感染创面愈合作用 [ 8 ]。然而改性壳聚糖的抗真菌作用仍需进一步体内实验验证。本研究首次将改性壳聚糖滴眼液应用于兔白念珠菌性角膜炎模型眼中,评价改性壳聚糖滴眼液的治疗作用及安全性,以期为临床治疗FK提供新的思路。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Wang L , Sun S , Jing Y ,et al. Spectrum of fungal keratitis in central China[J]. Clin Exp Ophthalmol, 2009,37(8):763-771. DOI: 10.1111/j.1442-9071.2009.02155.x .
返回引文位置Google Scholar
百度学术
万方数据
[2]
He D , Hao J , Gao S ,et al. Etiological analysis of fungal keratitis and rapid identification of predominant fungal pathogens[J]. Mycopathologia, 2016,181(1-2):75-82. DOI: 10.1007/s11046-015-9950-x .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Chang HY , Chodosh J . Diagnostic and therapeutic considerations in fungal keratitis[J]. Int Ophthalmol Clin, 2011,51(4):33-42. DOI: 10.1097/IIO.0b013e31822d64dc .
返回引文位置Google Scholar
百度学术
万方数据
[4]
姜亚萍陈轶卉真菌性角膜炎的治疗进展[J]国际眼科杂志 2015,(9):1542-1545. DOI: 10.3980/j.issn.1672-5123.2015.9.13 .
返回引文位置Google Scholar
百度学术
万方数据
Jiang YP , Chen YH . Advances of the treatment for fungal keratitis[J]. Intern J Ophthalmol, 2015, (9):1542-1545. DOI: 10.3980/j.issn.1672-5123.2015.9.13 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Ong HS , Corbett MC . Corneal infections in the 21st century[J]. Postgrad Med J, 2015,91(1080):565-571. DOI: 10.1136/postgradmedj-2015-133323 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Cheung RC , Ng TB , Wong JH ,et al. Chitosan:An update on potential biomedical and pharmaceutical applications[J]. Mar Drugs, 2015,13(8):5156-5186. DOI: 10.3390/md13085156 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Yong SK , Shrivastava M , Srivastava P ,et al. Environmental applications of chitosan and its derivatives[J]. Rev Environ Contam Toxicol, 2015,233:1-43. DOI: 10.1007/978-3-319-10479-9_1 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Zhu M , Liu P , Shi H ,et al. Balancing antimicrobial activity with biological safety:Bifunctional chitosan derivative for the repair of wounds with gram-positive bacterial infections[J]. Mate Chem B, 2018,6(23):3884-3893. DOI: 10.1039/c8tb00620b .
返回引文位置Google Scholar
百度学术
万方数据
[9]
刘廷徐园园陈豪改良角膜表面镜片术法建立兔曲霉菌性角膜炎动物模型[J]中华实验眼科杂志 201129(2):101-106. DOI: 10.3760/cma.j.issn.2095-0160.2011.02.002 .
返回引文位置Google Scholar
百度学术
万方数据
Liu T , Xu YY , Chen H ,et al. Rabbit model of aspergillus keratitis induced by modified corneal surface lens method[J]. Chin J Exp Ophthalmol, 2011,29(2):101-106. DOI: 10.3760/cma.j.issn.2095-0160.2011.02.002 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Gyanfosu L , Koffuor GA , Kyei S ,et al. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis[J]. Int Ophthalmol, 2018,38(5):2089-2100. DOI: 10.1007/s10792-017-0707-z .
返回引文位置Google Scholar
百度学术
万方数据
[11]
翟华蕾谢立信董晓光明胶酶在兔真菌性角膜炎病理改变中的作用研究[J]中华眼科杂志 200743(9):817-822. DOI: 10.3760/j.issn:0412-4081.2007.09.012 .
返回引文位置Google Scholar
百度学术
万方数据
Zhai HL , Xie LX , Dong XG . The roles of gelatinases in pathological changes of fungal keratitis in experimental rabbits[J]. Chin J Ophthalmol, 2007,43(9):817-822. DOI: 10.3760/j.issn:0412-4081.2007.09.012 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
葛坚王宁利眼科学[M]. 3版.北京人民卫生出版社 2015192.
[13]
Jurkunas U , Behlau I , Colby K . Fungal keratitis:changing pathogens and risk factors[J]. Cornea, 2009,28(6):638-643. DOI: 10.1097/ICO.0b013e318191695b .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Wu J , Zhang WS , Zhao J ,et al. Review of clinical and basic approaches of fungal keratitis[J]. Int J Ophthalmol, 2016,9(11):1676-1683. DOI: 10.18240/ijo.2016.11.23 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
中华医学会眼科学分会角膜病学组感染性角膜病临床诊疗专家共识(2011年)[J]中华眼科杂志 201248(1):72-75. DOI: 10.3760/cma.j.issn.0412-4081.2012.01.019 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Fernandes M , Vira D , Dey M ,et al. Comparison between polymicrobial and fungal keratitis:clinical features, risk factors, and outcome[J]. Am J Ophthalmol, 2015,160(5):873-881.e2. DOI: 10.1016/j.ajo.2015.07.028 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
翟华蕾谢立信真菌性角膜炎的临床研究进展[J]中华医学杂志 200787(33):2372-2374.
返回引文位置Google Scholar
百度学术
万方数据
[18]
Sowik M , Biernat MM , Urbaniak-Kujda D ,et al. Mycotic infections of the eye[J]. Adv Clin Exp Med, 2015,24(6):1113-1117. DOI: 10.17219/acem/50572 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Park HJ , Kim SH , Ju HW ,et al. Microplasma Jet arrays as a therapeutic choice for fungal keratitis[J]. Sci Rep, 2018,8(1):2422. DOI: 10.1038/s41598-018-20854-8 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Sahariah P , Másson M . Antimicrobial chitosan and chitosan derivatives:a review of the structure-activity relationship[J]. Biomacromolecules, 2017,18(11):3846-3868. DOI: 10.1021/acs.biomac.7b01058 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
唐大川杨红壳聚糖神经保护机制研究进展[J]中华实验眼科杂志 201432(3):281-284. DOI: 10.3760/cma.j.issn.2095-0160.2014.03.021 .
返回引文位置Google Scholar
百度学术
万方数据
Tang DC , Yang H . Current research of neuroprotective effect of chitosan[J]. Chin J Exp Ophthalmol, 2014,32(3):281-284. DOI: 10.3760/cma.j.issn.2095-0160.2014.03.021 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Matica MA , Aachmann FL , Tøndervik A ,et al. Chitosan as a wound dressing starting material:antimicrobial properties and mode of action[J/OL]. Int J Mol Sci, 2019,20(23):E5889[2019-02-11]. http://www.ncbi.nlm.nih.gov/pubmed/31771245. DOI: 10.3390/ijms20235889 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Wei S , Ching YC , Chuah CH . Synthesis of chitosan aerogels as promising carriers for drug delivery:A review[J/OL]. Carbohydr Polym, 2020,231:115744[2020-01-03]. http://www.ncbi.nlm.nih.gov/pubmed/31888854. DOI: 10.1016/j.carbpol.2019.115744 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Szymańska E , Winnicka K . Stability of chitosan-a challenge for pharmaceutical and biomedical applications[J]. Mar Drugs, 2015,13(4):1819-1846. DOI: 10.3390/md13041819 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Jia R , Duan Y , Fang Q ,et al. Pyridine-grafted chitosan derivative as an antifungal agent[J]. Food Chem, 2016,196:381-387. DOI: 10.1016/j.foodchem.2015.09.053 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Wei L , Mi Y , Zhang J ,et al. Evaluation of quaternary ammonium chitosan derivatives differing in the length of alkyl side-chain:Synthesis and antifungal activity[J]. Int J Biol Macromol, 2019,129:1127-1132. DOI: 10.1016/j.ijbiomac.2018.09.099 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
段文凯吕美巧郑春翠壳聚糖的结构及抑菌作用[J]现代食品科技 200622(4):259-261.
返回引文位置Google Scholar
百度学术
万方数据
Duan WK , Lyu MQ , Zheng CC ,et al. The structure of chitosan and its bacteriostatic effect[J]. Modern Food Sci Tech, 2006,22(4):259-261.
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
赵少贞,Email: mocdef.aabnis7991zsoahz
B
所有作者声明不存在利益冲突
C
天津市自然科学基金项目 (19JCYBJC25700)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号